ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network

Xie, Mingxiang; Zhang, Miaomiao; Qiao, Yuanyuan; Yang, Yibing; Xie, Fuda; Chen, Lichun; Liu, Na; Gu, Jiangyong*广州中医药大学; 北京大学; 南方医科大学; 5
Journal of Ethnopharmacology2024-1-10DOI: 10.1016/j.jep.2023.116935
1被引21阅读
引用收藏
分享

摘要

Ethnopharmacological relevance:Psoriasis is an inflammatory skin disease, there is no radical cure. Traditional Chinese medicine has accumulated a lot of clinical experience in the treatment of psoriasis and developed a variety of treatment methods, among which Yinxieling optimization formula (PSORI-CM01) have a definite clinical effect in the treatment of psoriasis, but their mechanism of action is still unclear. Aim of the study:To investigate the molecular mechanism of the PSORI-CM01 in the treatment of psoriasis. Materials and methods:Firstly, potential active compounds and key signaling pathways of PSORI-CM01 were explored by the systems pharmacology method. Then MTT assay was used to screen the potentially active compounds of PSORI-CM01, and explore the combined effects of potentially active compounds. The regulation of potentially active compounds on inflammatory factors were evaluated by a Human Th17 Magnetic Bead Panel. The regulation of PSORI-CM01 on key targets in the key signaling pathways were explored by qRT-PCR method. Finally, the molecular mechanism of PSORI-CM01 in the treatment of psoriasis was explained by the systems pharmacology method. Results:The potentially active compounds of PSORI-CM01 included gallic acid, liquiritigenin, rosmarinic acid, syringic acid, isoliquiritin apioside, caffeic acid, naringenin, cryptochlorogenic acid, (+)-taxifolin, p-coumaric acid, chlorogenic acid, fraxin, 5-hydroxymethylfurfural, lithospermic acid, isoliquiritigenin, salviandic acid B, octahydrocurcumin, catechin, syringaldehyde, methyl rosmarinate, paeonol, protocatechuic acid, astilbin, isoastilbin, isofraxidin and zederone. Both antagonistic and synergistic effects were determined in the combinations of active compounds. Most of the active compounds up-regulated IL-2, IL-6, IL-9 and TNF-& alpha;, and down-regulated IFN-& gamma;, IL-1 & beta;, IL-2, IL-9, IL-10, IL-13, IL-15, IL-17F, IL-21, IL-22 and IL-27. The PI3K-Akt signaling pathway would be the key signaling pathway of PSORI-CM01. The qRT-PCR results showed that its compounds can effectively regulate the expression of key targets in this pathway. Conclusions:The molecular mechanism of PSORI-CM01 for treating psoriasis would be mediated by regulating the network of inflammatory factors through the PI3K-Akt signaling pathway.

学科与关键词

关键词
PSORI-CM01HaCaT cellsInflammatory cytokinesSystems pharmacology
相关
加载中…
  • Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
    Lv, Shuying; Wang, Lei; Duan, Yuhang; Huang, Dan; Yang, Dingquan*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5764107.被引 1
  • Intervention Mechanism of Hunag-Lian Jie-Du Decoction on Canonical Wnt/β-Catenin Signaling Pathway in Psoriasis Mouse Model
    Yang, Xuesong*; Luo, Guangyun; Fu, Lan; Huang, Hong; Wang, Lifen; Yin, Lihua; Zhang, Xuelian; Wang, Tingting; Ma, Xuan; Feng, Tianyu; Ye, Jianzhou*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 3193572.被引 1
  • The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes
    Lu, Yue; Qi, Yao; Li, Li; Yan, Yuhong; Wei, Jianan; Yao, Danni; Wu, Jingjing; Deng, Hao; Deng, Jingwen; Ye, Shuyan; Chen, Haiming; Chen, Qubo; Gao, Hengjun*; Han, Ling*; Lu, Chuanjian*Frontiers in Pharmacology, 2022, 12: 759741.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2024-01-10
卷期
第 318 卷
页码
116935
DOI
10.1016/j.jep.2023.116935
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81904198]

作者

  • X

    Xie, Mingxiang (第一作者)

    guangzhou univ chinese med · 5 · southern med univ

  • Z

    Zhang, Miaomiao

    peking univ

查看全部 8 位作者收起作者
  • Q

    Qiao, Yuanyuan

    guangzhou univ chinese med

  • Y

    Yang, Yibing

    guangzhou univ chinese med

  • X

    Xie, Fuda

    guangzhou univ chinese med

  • C

    Chen, Lichun

    guangzhou univ chinese med

  • L

    Liu, Na

    guangzhou univ chinese med

  • G

    Gu, Jiangyong (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417